COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing
Top Cited Papers
Open Access
- 29 May 2021
- journal article
- research article
- Published by Elsevier BV in EClinicalMedicine
- Vol. 36, 100924
- https://doi.org/10.1016/j.eclinm.2021.100924
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samplesInternational Journal of Infectious Diseases, 2020
- Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational studyeLife, 2020
- Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020Eurosurveillance, 2020
- Clearance and persistence of SARS‐CoV‐2 RNA in patients with COVID‐19Journal of Medical Virology, 2020
- Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)Journal of Clinical Virology, 2020
- Evaluation of rapid antigen test for detection of SARS-CoV-2 virusJournal of Clinical Virology, 2020
- Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic ContextFrontiers in Medicine, 2020
- Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wardsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Evolution in Lateral Flow–Based Immunoassay SystemsPublished by Springer Science and Business Media LLC ,2008